The question of whether or not there is an increase in adrenal cortical secretion during pregnancy remains unsettled. Morphologic studies of the adrenal during gestation have revealed enlargement of the gland in some species (1) and no enlargement in others (2). In the human female, several groups of investigators have observed a progressive rise in the plasma 17-hydroxycorticosteroid (17-OH-corticosteroid) level during pregnancy (3-8). Paper chromatographic studies (9), confirmed in this laboratory (10), have indicated that the elevated plasma 17-OH-corticosteroid level is due to an increase in circulating hydrocortisone, and not to a nonspecific chromogen. Measurement of urinary 17-OH-corticosteroids has given equivocal results. Jayle, Desgrez, Serpicelli and Rozeg (11), Devis (12), Mills (13), and Appleby and Norymberski (14) found that the rise in urinary 17-OH-corticosteroids and 17-ketogenic steroids during pregnancy was of only moderate degree. Contradictory results have been obtained from studies of urinary 11-oxygenated 17-ketosteroids, the principal C19 metabolites of hydrocortisone (15). Dobriner, Lieberman, Rhoads and Taylor (16) crepancy between the finding of elevated plasma and of relatively normal urinary 17-OH-corticosteroid levels in pregnancy, Migeon, Bertrand and Wall investigated the rate of disappearance of injected 4-C14-hydrocortisone from plasma of pregnant women near term and found it to be delayed (20). These workers also observed a reduced rate of appearance of plasma and urine 17-OHcorticosteroid conjugates (glucuronides) after the administration of labeled hydrocortisone. These data suggested that the co-existence of high plasma (unconjugated) 17-OH-corticosteroid values and normal urine (unconjugated plus conjugated) 17-OH-corticosteroid values might be partly explained by the presence in both plasma and urine of a greater proportion of free hydrocortisone and a smaller proportion of conjugated hydrocortisone metabolites than normal (20). Devis (12) and Gray (21) have reported increased amounts of free 17-OH-corticosteroid in the urine of pregnant women. The present report describes studies upon the rate of hydrocortisone clearance from plasma in late pregnancy and in Laennec's cirrhosis, a condition in which hydrocortisone disposal rate is reportedly delayed (22)(23)(24). The data suggest that a delay in hydrocortisone clearance may not completely account for the elevated plasma 17-OHcorticosteroid levels observed in the pregnant state. MATERIALS AND METHODSPatients. Subjects were pregnant women in the third trimester of pregnancy who were not acutely ill and who showed no evidence of rheumatic heart disease, diabetes mellitus or pre-eclampsia. The women were hospitalized for premature rupture of the membranes or in anticipation of elective Caesarian section. Patients with Laennec's cirrhosis were six men and one woman with the typical clinical and laboratory features of parenchy-299
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.